Skip to main content Accessibility help
  • Print publication year: 2010
  • Online publication date: February 2010

5 - Modern genetics of reproductive biology


1. WolffeAP, MatzkeMA. Epigenetics: regulation through repression. Science 1999; 286: 481–6.
2. WaddingtonCH. Organisers and Genes. Cambridge: Cambridge University Press, 1940.
3. HollidayR, PughJE. DNA modification mechanisms and gene activity during development. Science 1975; 187: 226–32.
4. WillardHF, BrownCJ, CarrelL, HendrichB, MillerAP. Epigenetic and chromosomal control of gene expression: molecular and genetic analysis of X chromosome inactivation. Cold Spring Harbor Symp Quant Biol 1993; 58: 315–22.
5. MurrellA, RakyanVK, BeckS. From genome to epigenome. Human Mol Genet 2005; 14: R3–10.
6. JirtleRL, SkinnerMK. Environmental epigenomics and disease susceptibility. Nature Rev Genet 2007; 8: 253–62.
7. ReikW.Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 2007; 447: 425–32.
8. AmirRE, Van den VeyverIB, WanM. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet 1999; 23: 185–8.
9. FeinbergAP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007; 447: 433–40.
10. HorsthemkeB, BuitingK. Imprinting defects on human chromosome 15. Cytogenet Genome Res 2006; 113: 292–9.
11. EstellerM. Epigenetics in cancer. New Engl J Med 2008; 358: 1148–59.
12. HeindelJJ. Animal models for probing the developmental basis of disease and dysfunction paradigm. J Compil 2008; 102: 76–81.
13. KobayashiA, ShawlotW, KaniaA, BehringerRR. Requirement of Lim1 for female reproductive tract development. Development 2004; 131: 539–49.
14. SatokataI, BensonG, MaasR. Sexually dimorphic sterility phenotypes in Hoxa-10 deficient mice. Nature 1995; 374: 460–3.
15. MortlockDP, InnisJW. Mutation of HOXA13 in hand-foot-genital syndrome. Nature Genet 1997; 15: 179–80.
16. LimH, MaL, MaWG, MaasRL, DeySK. Hoxa-10 regulates uterine stromal cell responsiveness to progesterone during implantation and decidualization in the mouse. Mol Endocrinol 1999; 13: 1005–17.
17. TaylorHS, Vanden HeuvelGB, IgarashiP. A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol Reprod 1997; 57: 1338–45.
18. TaylorHS, AriciA, OliveD, IgarashiP. HOXA 10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest 1998; 101: 1379–84.
19. MillerC, SassoonDA. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 1998; 125: 3201–11.
20. PavlovaA, BoutinE, CunhaG, SassoonD. Msx1 (Hox-7.1) in the adult mouse uterus: cellular interactions underlying regulation of expression. Development 1994; 120: 335–46.
21. MillerC, PavlovaA, SassoonD. Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle. Mech Dev 1998; 76: 91–9.
22. KitajewskiJ, SassoonD. The emergence of molecular gynecology: homeobox and Wnt genes in the female reproductive tract. BioEssays 2000; 22: 902–10.
23. CunhaGR. Stromal induction and specification of morphogenesis and cytodifferentiation of the epithelia of the Müllerian ducts and urogenital sinus during development of the uterus and vagina in mice. J Exp Zool 1976; 196: 361–70.
24. KuritaT, MillsAA, CunhaGR. Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis. Development 2004; 131: 1639–49.
25. ZhaoY, PotterSS. Functional specificity of the Hoxa13 homeobox. Development 2001; 128: 3197–207.
26. ChengW, LiuJ, YoshidaH, RosenD, NaoraH. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nature Med 2005; 11: 531–7.
27. YoshidaH, BroaddusR, ChengW, XieS, NaoraH. Deregulation of the HOXA10 homeobox gene in endometrial carcinoma: role in epithelial-mesenchymal transition. Cancer Res 2006; 15:889–97.
28. TaylorHS, BagotC, KardanaA, OliveD, AriciA. HOX gene expression is altered in the endometrium of women with endometriosis. Human Reprod 1999; 14: 1328–31.
29. MarinoM, GalluzzoP, AscenziP. Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics 2006; 7: 497–508.
30. BigsbyRM, Caperell-GrantA, BerryN, NephewK, LubahnD. Estrogen induces a systemic growth factor through an estrogen receptor-alpha-dependent mechanism. Biol Reprod 2004; 70: 178–83.
31. CouseJF, KorachKS. Estrogen receptor null mice: what have we learned and where will they lead us?Endocr Rev 1999; 20: 358–417.
32. WatanabeH, SuzukiA, MizutaniT. et al. Genome-wide analysis of changes in early gene expression induced by estrogen. Genes Cells 2002; 7: 497–507.
33. SuzukiA, WatanabeH, MizutaniT. et al. Global gene expression in mouse vaginae exposed to diethylstilbestrol at different ages. Exp Biol Med 2006; 231: 632–40.
34. WatanabeH, SuzukiA, KobayashiM. et al. Similarities and differences in uterine gene expression patterns caused by treatment with physiological and non-physiological estrogen. J Mol Endocrinol 2003; 31: 487–97.
35. WatanabeH, SuzukiA, GotoM. et al. Tissue-specific estrogenic and non-estrogenic effects of a xenoestrogen, nonylphenol. J Mol Endocrinol 2004; 33: 243–52.
36. WatanabeH, SuzukiA, GotoM. et al. Comparative uterine gene expression analysis after dioxin and estradiol administration. J Mol Endocrinol 2004; 33: 763–71.
37. KobayashiM, TakahashiE, MiyagawaS, WatanabeH, Iguchi, T.Chromatin immunoprecipitation-mediated identification of aquaporin 5 as a regulatory target of estrogen in the uterus. Genes Cells 2006; 11: 1133–43.
38. LinCY, VegaVB, ThomsenJS. et al. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet 2007; 3: e87.
39. ProssnitzER, ArterburnJB, SklarLA. GPR30: a G protein-coupled receptor for estrogen. Mol Cell Endocrinol 2007; 265–266: 138–42.
40. DamstraT, BarlowS, BergmanA, KavlockR, Van Der KraakG (eds.) Global Assessment of the State-of-the-Science of Endocrine Disruptors. WHO/IPCS, 2002.
41. TakasugiN, BernHA, DeOmeKB. Persistent vaginal cornification in mice. Science 1962; 138: 438–9.
42. IguchiT. Cellular effects of early exposure to sex hormones and antihormones. Int Rev Cytol 1992; 139: 1–57.
43. HerbstAL, BernHA (eds.) Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. New York: Thieme Stratton Inc., 1981.
44. McLachlanJA, NewboldRR, BullockBC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 1980; 40: 3988–99.
45. MaL, BensonG, LimH, DeySK, MaasRL. Abdominal B (AbdB) hoax genes: regulation in adult uterus by estrogen and progesterone and repression in Müllerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol 1998; 197: 141–54.
46. HuangWW, YinY, BiQ. et al.Developmental diethylstilbestrol exposure alters genetic pathways of uterine cytodifferentiation. Mol Endocrinol 2005; 19: 669–82.
47. BlockK, KardanaA, IgarashiP, TaylorHS. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing Müllerian system. FASEB J 2000; 14: 1101–8.
48. MillerC, DegenhardtK, SassoonDA. Fetal exposure to DES results in de-regulation of Wnt7a during uterine morphogenesis. Nature Genet 1998; 20: 228–30.
49. CouseJF, DixonD, YatesM. et al. Estrogen receptor-α knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract. Dev Biol 2001; 238: 224–38.
50. FeiX, ChungH, TaylorHS. Methoxychlor disrupts uterine Hoxa10 gene expression. Endocrinology 2005; 146: 3445–51.
51. IguchiT, FukazawaY, BernHA. Effects of sex hormones on oncogene expression in the vagina and on the development of sexual dimorphism of the pelvis and anococcygeous muscle in the mouse. Environ Health Perspect 1995; 103: 79–82.
52. KamiyaK, SatoT, NishimuraN. et al. Expression of estrogen receptor and proto-oncogene messenger ribonucleic acids in reproductive tracts of neonatally diethylstilbestrol-exposed female mice with or without postpubertal estrogen administration. Exp Clin Endocrinol Diabetes 1996; 104: 111–22.
53. LiS, HansmanR, NewboldRR. et al. Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog 2003; 38: 78–84.
54. MiyagawaS, KatsuY, WatanabeH, IguchiT.Estrogen-independent activation of ErbBs signaling and estrogen receptor α in the mouse vagina exposed neonatally to diethylstilbestrol. Oncogene 2004; 23: 340–9.
55. MiyagawaS, SuzukiA, KatsuY. et al. Persistent gene expression in mouse vagina exposed neonatally to diethylstilbestrol. J Mol Endocrinol 2004; 32: 663–77.
56. MatsudaM, MasuiF, MoriT. Neonatal estrogenization leads to increased expression of cellular retinol binding protein 2 in the mouse reproductive tract. Cell Tissue Res 2004; 316: 131–9.
57. MasuiF, KuraosakiK, MoriT, MatsudaM. Persistent trefoil factor 1 expression imprinted on mouse vaginal epithelium by neonatal estrogenization. Cell Tissue Res 2006; 323: 167–75.
58. KatoH, FuruhashiT, TanakaM. et al. Effects of bisphenol A given neonatally on reproductive functions of male rats. Reprod Toxicol 2006; 22: 20–9.
59. NakamuraT, KatsuY, WatanabeH, IguchiT. Estrogen receptor subtypes selectively mediate female mouse reproductive abnormalities induced by neonatal exposure to estrogenic chemicals. Toxicology 2008; 253; 117–24.
60. NewboldRR, Padilla-BanksE, JeffersonWN. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 2006; 147: S11–17.
61. TurusovVS, TrukhanovaLS, Parfenov YuD, TomatisL.Occurrence of tumours in the descendants of CBA male mice prenatally treated with diethylstilbestrol. Int J Cancer 1992; 50: 131–5.
62. WalkerBE, HavenMI. Intensity of multigenerational carcinogenesis from diethylstilbestrol in mice. Carcinogenesis 1997; 18: 791–3.
63. TomatisL.Transgeneration carcinogenesis: a review of the experimental and epidemiological evidence. Jpn J Cancer Res 1994; 85: 443–54.
64. Titus-ErnstoffL, TroisiR, HatchEE. et al. Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES). Int J Epidemiol 2006; 35: 862–8.
65. LiS, WashburnKA, MooreR. et al. Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactotransferrin gene in the mouse uterus. Cancer Res 1997; 57: 4356–9.
66. LiS, MaL, ChiangT. et al. Promoter CpG methylation of Hox-a10 and Hox-a11 in mouse uterus not altered upon neonatal diethylstilbestrol exposure. Mol Carcinog 2001; 32: 213–19.
67. AlworthLC, HowdeshellKL, RuhlenRL. et al. Uterine responsiveness to estradiol and DNA methylation are altered by fetal exposure to diethylstilbestrol and methoxychlor in CD-1 mice: effects of low versus high doses. Toxicol Appl Pharmacol 2002; 183: 10–22.
68. RudenDM, XiaL, GarfinkelMD, LuX. Hsp90 and environmental impacts on epigenetic stages: a model for the trans-generational effects of diethylstilbestrol on uterine development and cancer. Human Mol Genet 2005; 14: R149–55.
69. CrewsD, McLachlanJA. Epigenetics, evolution, endocrine disruption, health, and disease. Endocrinology 2006; 147: S4–10.
70. AnwayMD, CuppAS, UzumcuM, SkinnerMK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005; 308: 1466–9.
71. KawabeM, TakahashiS, DoiY. et al. Maternal exposure to anti-androgenic compounds has no effects on spermatogenesis and DNA methylation in male rats of subsequent generation. Abstract 264, Int Congress Toxicol 2007.
72. McMillenIC, RobinsonJS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85: 571–633.
73. CrainDA, JanssenSJ, EdwardsTM. et al. Female reproductive disruption: the roles of endocrine disrupting compounds and developmental timing. Fertil Steril 2008; 90: 911–40.
74. WaterlandR, JirtleR. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23: 5293–300.
75. DolinoyDC, WiedmanJ, WaterlandR, JirtleRL. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 2006; 114: 567–72.
76. DolinoyDC, HuangD, JirtleRL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA 2007; 104: 13056–61.
77. GluckmanPD, LillycropKA, VickersMH. et al. Metabolic plasticity during mammalian development is directionally dependent on early nutritional status. Proc Natl Acad Sci USA 2007; 104: 12796–800.
78. PrinsGS, TangW-Y, BelmonteJ, HoS-M. Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. J Comp 2008; 102: 134–8.
79. HoS-M, TangW-Y, Belmonte de FraustoJ, PrinsGS. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 2006; 66: 5624–32.
80. WuQ, OhsakoS, IshimuraR, SuzukiJS, TohyamaC. Exposure of mouse preimplantation embryos to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the methylation status of imprinted genes H19 and Igf2. Biol Reprod 2004; 70: 1790–7.